United States · FDA National Drug Code directory

Adasuve

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
51097-001_55f64763-e6eb-4ca3-e063-6394a90a2541
Product NDC
51097-001
Form
AEROSOL, POWDER
Composition / generic term
loxapine
Labeler
Alexza Pharmaceuticals, Inc.
Marketing category
NDA
Marketing start / end (source format)
20260706
Source listing expiry
20271231

Source-listed ingredients

  • LOXAPINE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 5 INHALER in 1 CARTON (51097-001-02) / 1 AEROSOL, POWDER in 1 INHALER (51097-001-01) · 51097-001-02

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →